Beverly, MA, United States of America

Daniel Mulhern

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Mulhern

Introduction

Daniel Mulhern is an accomplished inventor based in Beverly, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of methylation and acetylation research. His work has implications for diagnostics and therapeutics, showcasing the importance of understanding cellular modifications.

Latest Patents

Daniel Mulhern holds a patent related to "Methylation and acetylation sites." This patent features over 5000 identified methylation and acetylation sites in human cell lines, human serum, and mouse tissues. It includes peptides, such as AQUA peptides, that comprise these sites, as well as antibodies that specifically bind to them. The patent also discusses the diagnostic and therapeutic uses of these findings, highlighting their potential impact on medical science.

Career Highlights

Daniel is currently employed at Cell Signaling Technology, Inc., where he continues to advance research in the field. His work at this company has allowed him to collaborate with other talented scientists and contribute to innovative projects that push the boundaries of biotechnology.

Collaborations

Some of his notable coworkers include Hongbo Gu and Ailan Guo. Their collaborative efforts have further enriched the research environment at Cell Signaling Technology, Inc.

Conclusion

Daniel Mulhern's contributions to the field of biotechnology through his patent and work at Cell Signaling Technology, Inc. demonstrate his commitment to advancing scientific knowledge and improving diagnostic and therapeutic methods. His innovative spirit continues to inspire those in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…